Cancer BiologybioRxivPreprint
A Drosophila in vivo chemical screen reveals that combination drug treatment targeting MEK and DGKα mitigates Ras-driven polarity-impaired tumourigenesis.
H. E. Richardson, J. E. La Marca, R. W. Ely…·P. O. Humbert
This paper identifies a combination of MEK and DGKα inhibitors that reduces Ras-driven tumourigenesis in Drosophila and human cells.
DOI 10.1101/2022.03.14.484232